Literature DB >> 160860

The probability of side effects with ovral, norinyl 1/50 and norlestrin.

G S Berger, D A Edelman, P P Talwar.   

Abstract

This report provides specific information on the prevalence rates of the most common side effects during the first 3 cycles of use of 3 combination oral contraceptives (OCs) containing 50 mcg estrogen. The probabilities of a symptom occurring for the first time, or persisting once present, during the initial cycles of OC use are given for each of the 3 combined OCs.

Entities:  

Keywords:  Bleeding; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Diseases; Ethinyl Estradiol; Family Planning; Measurement; Mestranol; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norethynodrel; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Prevalence; Research Methodology; Signs And Symptoms; Studies

Mesh:

Substances:

Year:  1979        PMID: 160860     DOI: 10.1016/0010-7824(79)90050-7

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  1 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.